Citigroup Inc.
Citigroup Inc. (C-PJ) Financial Performance & Income Statement Overview
Analyze Citigroup Inc. (C-PJ) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Citigroup Inc. (C-PJ) Income Statement & Financial Overview
View the income breakdown for Citigroup Inc. C-PJ across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $17.02B | $19.86B | $20.14B | $21.09B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $17.02B | $19.86B | $20.14B | $21.09B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $7.26B | $7.37B | $7.19B | $7.93B |
| Operating Expenses | $10.17B | $13.15B | $13.22B | $13.38B |
| Total Costs & Expenses | $10.17B | $13.15B | $13.22B | $13.38B |
| Interest Income | $0.00 | $36.46B | $35.99B | $36.22B |
| Interest Expense | $0.00 | $23.09B | $22.49B | $22.72B |
| Depreciation & Amortization | $1.02B | $1.08B | $1.10B | $1.11B |
| EBITDA | $4.13B | $7.80B | $8.03B | $8.83B |
| EBITDA Ratio | $0.24 | $0.00 | $0.34 | $0.41 |
| Operating Income | $6.85B | $6.72B | $6.93B | $7.72B |
| Operating Income Ratio | $0.40 | $0.18 | $0.34 | $0.35 |
| Other Income/Expenses (Net) | -$3.05B | -$2.33B | -$2.62B | -$3.17B |
| Income Before Tax | $3.80B | $4.39B | $4.31B | $4.54B |
| Income Before Tax Ratio | $0.22 | $0.25 | $0.21 | $0.22 |
| Income Tax Expense | $912.00M | $1.12B | $1.05B | $1.14B |
| Net Income | $2.86B | $3.24B | $3.22B | $3.37B |
| Net Income Ratio | $0.17 | $0.18 | $0.16 | $0.16 |
| EPS | $1.21 | $1.54 | $1.54 | $1.59 |
| Diluted EPS | $1.35 | $1.51 | $1.52 | $1.58 |
| Weighted Avg Shares Outstanding | $2.15B | $1.90B | $1.91B | $1.91B |
| Weighted Avg Shares Outstanding (Diluted) | $1.93B | $1.94B | $1.95B | $1.93B |
The company's financials show resilient growth, with revenue advancing from $21.09B in Q1 2024 to $17.02B in Q4 2024. Gross profit remained healthy with margins at 100% in Q4 2024 compared to 100% in Q1 2024. Operating income hit $6.85B last quarter, sustaining a consistent 40% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $4.13B. Net income dropped to $2.86B, while earnings per share reached $1.21. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan